Australia's CSL to supply vaccines to Canada in case of flu pandemic; shares jump

Csl

05/03/2026 04:45

** Shares of CSL CSL.AX rise as much as 3.5% to A$147.90, their highest level since February 24

** Co's vaccine business, CSL Seqirus, wins contract to support influenza pandemic preparedness plans of the Canadian government, per Australia-Canada joint statement

** CSL Seqirus' advanced cell-based vaccine manufacturing facility in Australia to supply Canada with 15 million vaccines in the event of a pandemic

** Stock down 15% this year, including the day's move

(Reporting by Sherin Sunny in Bengaluru)

((Sherin.Sunny@thomsonreuters.com))